FBXO5 and breast cancer: Down‐regulation of EMI1 interferes with DNA synthesis in varieties of tumour, such as glioblastoma and breast cancer, inhibiting cancer cell growth and enhancing its sensitivity to chemotherapy and radiation therapy.54